10 Small Submissions
No more than 10 Documents per submission
Country: China
Health Authority: National Medical Products Administration (NMPA)
eCTD, Accepted Since: Dec 29, 2021
eCTD Version: eCTD CN V1.0 DTD V1.0, M2-M5 - v3.2.2
The China National Medical Products Administration (NMPA) supports “Investigational New Drugs applications (IND), New Drug Applications (NDA) and Abbreviated New Drug Applications (ANDA) Application Types.
USA, EU, Health Canada, Switzerland, South Africa, Australia, EAEU, Jordan, Thailand, GCC, ASEAN